793 related articles for article (PubMed ID: 18991338)
1. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
[TBL] [Abstract][Full Text] [Related]
2. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
3. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
Ng SY; Villemagne VL; Masters CL; Rowe CC
Arch Neurol; 2007 Aug; 64(8):1140-4. PubMed ID: 17698704
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
[TBL] [Abstract][Full Text] [Related]
5. Dual-phase
Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
Taswell C; Villemagne VL; Yates P; Shimada H; Leyton CE; Ballard KJ; Piguet O; Burrell JR; Hodges JR; Rowe CC
J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
[TBL] [Abstract][Full Text] [Related]
7. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
[TBL] [Abstract][Full Text] [Related]
8. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
Bunai T; Kakimoto A; Yoshikawa E; Terada T; Ouchi Y
J Alzheimers Dis; 2019; 69(2):529-538. PubMed ID: 31104023
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
[TBL] [Abstract][Full Text] [Related]
10. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
[TBL] [Abstract][Full Text] [Related]
11. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
[TBL] [Abstract][Full Text] [Related]
12. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
[TBL] [Abstract][Full Text] [Related]
13. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
[TBL] [Abstract][Full Text] [Related]
14. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
[TBL] [Abstract][Full Text] [Related]
15. Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes.
Beaufils E; Vercouillie J; Vierron E; Cottier JP; Camus V; Mondon K; Guilloteau D; Hommet C; Ribeiro MJ
Clin Nucl Med; 2018 Apr; 43(4):e103-e108. PubMed ID: 29504965
[TBL] [Abstract][Full Text] [Related]
16. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
17. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.
Schaeverbeke J; Gabel S; Meersmans K; Bruffaerts R; Liuzzi AG; Evenepoel C; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
Alzheimers Res Ther; 2018 Jul; 10(1):68. PubMed ID: 30021613
[TBL] [Abstract][Full Text] [Related]
18. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
Jiménez-Bonilla JF; Banzo I; De Arcocha-Torres M; Quirce R; Martínez-Rodríguez I; Lavado-Pérez C; Bravo-Ferrer Z; Rodríguez-Rodríguez E; Sánchez-Juan P; Carril JM
Nucl Med Commun; 2016 Nov; 37(11):1189-96. PubMed ID: 27341411
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
